Home > Products > Tumor Cell Lines > Human Tumor Cell Lines >
BT-474 | ||||
|---|---|---|---|---|
| Product Name | BT-474 | |||
| Price | Get Quote | |||
| Product Code | Bt-474; BT474 | |||
| Cat.No | ABC-TC0085 | Species | Human | |
| Size/Quantity | 1 vial | Biosafety Level | 1 | |
| Shipping Info | Dry Ice | Storage | Liquid Nitrogen | |
| Description | The BT-474 cell line, originating from a 60-year-old White female breast cancer patient, showcases epithelial traits and emerges from an invasive ductal carcinoma of the breast. Notably, the BT-474 cells are identified as estrogen receptor positive (ER), progesterone receptor positive (PR),
Why choose BT-474 from AcceGen? AcceGen’s BT-474 cell line features exceptional viability and quality, confirmed through rigorous quality control measures. The cells are maintained in a sterile environment and have been thoroughly tested to ensure they are free from bacterial, fungal, and mycoplasma contamination. Identity verification utilizing STR analysis further guarantees the authenticity and reliability of the BT-474 cell line. | |||
| Disease | Ductal Cancer | |||
| Source Organ | Breast | |||
| Recommended Medium And Supplement | RPMI 1640 + 20% FBS + 10 ug/mL Human Insulin | |||
| Citation Guide | When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID). | |||
| Application | FOR RESEARCH USE ONLY The BT-474 cell line finds valuable applications in preclinical breast cancer research, offering a direct link to real patients with matching genetic profiles. This model proves indispensable in drug discovery endeavors, facilitating the development of innovative targeted treatments for breast cancer. Its utilization spans from investigating small molecules and antibodies to refining cell-based therapies, enhancing the prospects of advancing effective interventions for breast cancer patients. | |||
| Growth Conditions | 37 ℃, 5% CO2 | |||
| Cell Type | Epithelial | |||
| Growth Mode | Adherent | |||
| Product Type | Human Breast Cancer Cell Lines | |||
| Product Image |  | |||
and human epidermal growth factor receptor 2 positive (HER2). These cells form compact, slowly growing multi-layered colonies, rarely achieving confluence and failing to create a continuous monolayer. Impressively, they exhibit tumorigenic characteristics in athymic mice and demonstrate susceptibility to the mouse mammary tumor virus. Additionally, a mutation in the TP53 gene is identified within the BT-474 cell line.- ONLINE INQUIRY
- PRODUCT REVIEWS
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
